NextCell Pharma (Sweden) Probability of Future Stock Price Finishing Under 6.3
NextCell Pharma's future price is the expected price of NextCell Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of NextCell Pharma AB performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Please specify NextCell Pharma's target price for which you would like NextCell Pharma odds to be computed.
NextCell |
NextCell Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NextCell Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NextCell Pharma AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NextCell Pharma AB is not yet fully synchronised with the market data | |
| NextCell Pharma AB has some characteristics of a very speculative penny stock | |
| NextCell Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.59 M. Net Loss for the year was (35.02 M) with loss before overhead, payroll, taxes, and interest of (2.49 M). | |
| NextCell Pharma AB has accumulated about 150.75 M in cash with (33.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.39. | |
| Roughly 43.0% of the company outstanding shares are owned by corporate insiders |
NextCell Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NextCell Stock often depends not only on the future outlook of the current and potential NextCell Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NextCell Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 34.4 M | |
| Cash And Short Term Investments | 97.1 M |
NextCell Pharma Technical Analysis
NextCell Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. NextCell Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NextCell Pharma AB. In general, you should focus on analyzing NextCell Stock price patterns and their correlations with different microeconomic environments and drivers.
NextCell Pharma Predictive Forecast Models
NextCell Pharma's time-series forecasting models is one of many NextCell Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary NextCell Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about NextCell Pharma AB
Checking the ongoing alerts about NextCell Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for NextCell Pharma AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| NextCell Pharma AB may become a speculative penny stock | |
| NextCell Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.59 M. Net Loss for the year was (35.02 M) with loss before overhead, payroll, taxes, and interest of (2.49 M). | |
| NextCell Pharma AB has accumulated about 150.75 M in cash with (33.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 43.0% of the company outstanding shares are owned by corporate insiders |
Additional Tools for NextCell Stock Analysis
When running NextCell Pharma's price analysis, check to measure NextCell Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCell Pharma is operating at the current time. Most of NextCell Pharma's value examination focuses on studying past and present price action to predict the probability of NextCell Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCell Pharma's price. Additionally, you may evaluate how the addition of NextCell Pharma to your portfolios can decrease your overall portfolio volatility.